Dode L, Wuytack F, Kools P F, Baba-Aissa F, Raeymaekers L, Briké F, van de Ven W J, Casteels R
Laboratorium voor Fysiologie, Vlaams interuniversitair instituut voor Biotechnologie, Katholieke Universiteit Leuven, Belgium.
Biochem J. 1996 Sep 1;318 ( Pt 2)(Pt 2):689-99. doi: 10.1042/bj3180689.
cDNA and genomic clones encoding human sarco/endoplasmic reticulum Ca(2+)-ATPase 3 (SERCA3) were isolated. The composite nucleotide sequence of the 4.6 kb cDNA, as well as the partial structure of 25 kb of genomic DNA encoding all but the 5' region of the gene, was determined. The nucleotide sequence coding for the last six amino acids of the pump and the 3'-untranslated region were identified within the sequence of the last exon. Northern blot hybridization analysis using cDNA probes derived from this exon detected a 4.8 kb transcript in several human tissues. Using a cDNA probe derived from the 5'-coding region an unexpected mRNA distribution pattern, consisting of two mRNA species of 4.8 and 4.0 kb, was detected in thyroid gland and bone marrow only. This is the first indication of an alternative splicing mechanism operating on the SERCA3 gene transcript, which most likely generates SERCA3 isoforms with altered C-termini. Human SERCA3 expressed in platelets and in COS cells transfected with the corresponding cDNA was detected with the previously described antibody N89 (directed against the N-terminal region of rat SERCA3) and with a new SERCA3-specific antiserum C91, directed against the extreme C-terminus of the human isoform. A monoclonal antibody PL/IM430, previously assumed to recognize SERCA3 in human platelets, does not react with the 97 kDa human SERCA3 transiently expressed in COS cells. Therefore the 97 kDa isoform detected by PL/IM430 more likely represents a novel SERCA pump, as recently suggested [Kovács, Corvazier, Papp, Magnier, Bredoux, Enyedi, Sarkadi and Enouf (1994) J. Biol. Chem. 269, 6177-6184]. Finally, by fluorescence in situ hybridization and chromosome G-banding analyses, the SERCA3 gene was assigned to human chromosome 17p13.3.
分离出了编码人肌浆网/内质网Ca(2+)-ATP酶3(SERCA3)的cDNA和基因组克隆。确定了4.6 kb cDNA的复合核苷酸序列以及编码该基因除5'区域外所有部分的25 kb基因组DNA的部分结构。在最后一个外显子的序列中鉴定出了编码该泵最后六个氨基酸的核苷酸序列和3'非翻译区。使用源自该外显子的cDNA探针进行的Northern印迹杂交分析在几种人体组织中检测到了一个4.8 kb的转录本。使用源自5'编码区的cDNA探针,仅在甲状腺和骨髓中检测到了一种由4.8 kb和4.0 kb两种mRNA组成的意外mRNA分布模式。这是SERCA3基因转录本存在可变剪接机制的首个迹象,该机制很可能产生C末端改变的SERCA3亚型。用先前描述的抗体N89(针对大鼠SERCA3的N末端区域)和一种针对人亚型极端C末端的新的SERCA3特异性抗血清C91检测了在血小板中以及用相应cDNA转染的COS细胞中表达的人SERCA3。先前认为能识别人血小板中SERCA3的单克隆抗体PL/IM430,不与在COS细胞中瞬时表达的97 kDa人SERCA3发生反应。因此,如最近所提示的[科瓦奇、科尔瓦齐耶、帕普、马涅尔、布雷杜、埃内迪、萨尔卡迪和埃努夫(1994年)《生物化学杂志》269,6177 - 6184],PL/IM430检测到的97 kDa亚型更可能代表一种新的SERCA泵。最后,通过荧光原位杂交和染色体G带分析,将SERCA3基因定位于人染色体17p13.3。